OTC : USAQ

QHSLab, Inc.

$0.35 USD

$0 (0.0%)

Volume
10K
Average Volume
6.87K
Market Capitalization
$5.26M
P/E Ratio
7.38
Dividend Yield
0.00%
Price Target
Year High
$1.14
Year Low
$0.08
Day High
Day Low
Payout Ratio
$0.06
Current Ratio
$1.82
Company Overview

OTC

Troy James Grogan

Medical - Devices

Healthcare

USAQ

12

US

USD

929 379 6503

90350R107

0000856984

Liquidity Metrics

0.00

1.82

1.79

0.84

0.06

Sales & Valuation

$2.69M

1.74

3.37

-48.98

-0.01

Profitability

$0.02

$457.42K

17.37%

17.37%

51.21%

27.09%

P/E Metrics

7.38

0.03

0.03

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

6.74

5/9

$251.05K

$1.89M

$368K

$612.49K

Key Metrics (TTM)

$5.03M

1.81

7.35

1.68

91.63%

2.96%

8.23%

0.52%

$0.26

-47 days

Company Executives
Name Title
Olivia Giamanco Marketing Director
Troy James Grogan Chief Executive Officer, Chief Financial Officer, President & Chairman
Cyndi Cole Financial Controller
Poll Results

No votes yet today — be the first to share your view!

About QHSLab, Inc. (OTC:USAQ) Stock

QHSLab, Inc. is a company operating in the medical technology and Software-as-a-Service (SaaS) sectors. Its core focus is on advancing value-based healthcare, medical informatics, and personalized medicine driven by algorithms. The firm also develops digital therapeutic solutions and on-site technologies intended for remote patient oversight, the management of chronic conditions, and proactive health maintenance. Among its offerings is a proprietary cloud-based SaaS platform, also known as QHSLab (Quality Health Score Lab expert system). This system empowers physicians and healthcare organizations to securely record and store electronic patient data. Additionally, QHSLab, Inc. acts as a distributor, providing primary care physicians with AllergiEnd, a product line encompassing diagnostic t ... ools and allergen immunotherapy treatments. All of its solutions are strategically designed to aid in the prevention, early identification, effective management, and potential reversal of chronic diseases. The company was established in 1983 and is headquartered in West Palm Beach, Florida. It operated under the name USA Equities Corp. until April 2022, when it officially rebranded to QHSLab, Inc. The company also maintains a strategic partnership with Medical License Factory, LLC.

QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results

2026-08-03 08:30:00

Integrated Service Program (ISP) Revenue More Than Doubles Year-over-Year as Gross Margins Expand and Financing Costs Decline

Frequently Asked Questions

What is the current QHSLab, Inc. (USAQ) stock price?

QHSLab, Inc.(OTC:USAQ) stock price is $0.35 in the last trading session. During the trading session, USAQ stock reached the peak price of $1.136 while $0.08 was the lowest point it dropped to. The percentage change in USAQ stock occurred in the recent session was 0.0% while the dollar amount for the price change in USAQ stock was $0.

USAQ's industry and sector of operation?

The OTC listed USAQ is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of USAQ?

Olivia Giamanco | Marketing Director
Troy James Grogan | Chief Executive Officer, Chief Financial Officer, President & Chairman
Cyndi Cole | Financial Controller
|
|

How many employees does USAQ have?

Number of USAQ employees currently stands at 12. USAQ operates from 901 Northpoint Parkway, West Palm Beach, FL 33407, US.

Link for USAQ official website?

Official Website of USAQ is: https://www.qhslab.com

How do I contact USAQ?

USAQ could be contacted at phone #929 379 6503 and can also be accessed through its website. USAQ operates from 901 Northpoint Parkway, West Palm Beach, FL 33407, US.

How many shares of USAQ are traded daily?

The average number of USAQ shares traded daily for last 3 months was 6.87K.

What is the market cap of USAQ currently?

The market value of USAQ currently stands at $5.26M with its latest stock price at $0.35